A hepatitis B health alert has been issued to ... The Blood Borne Viruses Advisory Panel reviewed work carried out by the healthcare worker and determined the risk of transmission was low for ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-stage biotechnology company pioneering innovative therapies for cancer and viral infections, announces that its chief medical officer, Roger ...

The American Gastroenterological Association (AGA) has released an updated clinical practice guideline on the prevention of hepatitis B virus ... of the questions, the panel was satisfied with ...

Despite the risk of transmission being low, the NSW Blood Borne Viruses Advisory Panel has determined about ... who may have been exposed to low-risk hepatitis B while giving birth at Nepean ...

“The NSW Health Blood Borne Viruses Advisory Panel has reviewed the care provided ... at Nepean Hospital are being urged to test for hepatitis B. “Nepean Blue Mountains Local Health District ...

Overdose prevention centers can save the lives and improve the health and well-being of CT people addicted to drugs – ...

The decision to end research on vaccine hesitancy is deeply disrespectful of those who have lost or will lose loved ones to ...

It has been discovered that a healthcare worker at at Nepean Hospital's Birth Unit was infectious with hepatitis B between 2013 and 2024.

Health and Human Services is cutting at least $73 million in funding from Columbia University in an effort that the Trump ...

Based upon a successful engagement with the US Food and Drug Administration (FDA) at the End-of-Phase 2 meeting in January 2025, Atea is initiating a global Phase 3 program and expects patient ...

The global in vitro diagnostics market (IVD) was valued at $67,111 million in 2019, and is projected to reach $91,093 million at a CAGR of 4.8% from 2020 to 2027. For instance, in clinical chemistry ...